Ubilla Ricardo, Zeppelin Michelle, Martin Fernanda
Departamento de Genética, Hospital Luis Calvo Mackenna, Santiago 7500539, Chile.
Unidad Genética, Hospital Clínico Universidad de Chile, Santiago 8380456, Chile.
Ecancermedicalscience. 2024 May 10;18:1701. doi: 10.3332/ecancer.2024.1701. eCollection 2024.
Multilocus inherited neoplasia allelic syndrome (MINAS) is a recently coined term that describes the coexistence of two or more pathogenic variants (PVs) in cancer susceptibility genes (CSGs) in a single individual.
This article presents two cases of MINAS due to rare CSG combinations. The first was a 37-year-old woman carrying PVs in the mutated ataxia telangiectasia () and genes, with HER-2 positive unilateral breast cancer at 29. The second was a 53-year-old woman carrying PVs in the and genes, who presented with triple-negative breast cancer at 51. We describe their family history and treatment, where the lack of evidence for personalised management becomes evident.
Predicting the phenotypic effect of harbouring two variants in CSG is challenging. It is essential to encourage the notification of other cases and carry out functional studies to establish specific risks for affected individuals to develop personalised follow-up guidelines to reduce the associated morbimortality.
多基因座遗传性肿瘤等位基因综合征(MINAS)是一个最近创造的术语,用于描述单个个体中癌症易感基因(CSG)存在两个或更多致病变异(PV)的情况。
本文介绍了两例由罕见CSG组合导致的MINAS病例。第一例是一名37岁女性,其共济失调毛细血管扩张突变基因()和基因存在PV,29岁时患HER-2阳性单侧乳腺癌。第二例是一名53岁女性,其基因和基因存在PV,51岁时患三阴性乳腺癌。我们描述了她们的家族史和治疗情况,其中个性化管理缺乏证据的情况变得很明显。
预测CSG中携带两个变异的表型效应具有挑战性。必须鼓励报告其他病例并开展功能研究,以确定受影响个体的特定风险,从而制定个性化的随访指南,以降低相关的病残率和死亡率。